by EmpathiCSubstanceS | Nov 1, 2018 | Depression
Psychedelic psilocybin therapy for depression granted Breakthrough Therapy status by FDA In an extraordinary step forward for the psychedelic drug research community, the US Food and Drug Administration (FDA) has just given psilocybin therapy for treatment-resistant...
by EmpathiCSubstanceS | Sep 21, 2018 | PTSD
As final trials move to establish MDMA-assisted psychotherapy as a legal and legitimate clinical treatment, a new study has recently been published demonstrating the results of the world’s first clinical trial for another, albeit more controversial, application...
by EmpathiCSubstanceS | Sep 21, 2018 | Anxiety
When humans take the drug MDMA, versions of which are known as molly or ecstasy, they commonly feel very happy, extraverted, and particularly interested in physical touch. A group of scientists recently wondered whether this drug might have a similar effect on other...
by EmpathiCSubstanceS | Sep 1, 2018 | Addiction, Alcoholism
Everyone’s hoping a little LSD can lead them to the next billion-dollar idea. Over the past year, at lunches with various Silicon Valley entrepreneurs, I have been told at least four times that magic mushrooms will help me become a better reporter (maybe) and three...
by EmpathiCSubstanceS | Sep 1, 2018 | Anxiety, Cannabis Marijuana, Chronic Pain, Depression, Iboga, Kambo, MDMA Sassafras Molly, Neuropathy, OCD
Dennis van der Meijden isn’t aiming to see the face of God, feel one with the cosmos, grasp the hidden reality of time and space, or embark on a sacred journey. What the Dutch graphic designer, producer, and rapper (under the professional name Terilekst) wants—and...
